Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology

Journal of Comparative Neurology

Volumn 521, Issue 18, 2013, Pages 4236-4248

  Pooler, Amy M ^a,b   Polydoro, Manuela ^b   Wegmann, Susanne K ^b   Pitstick, Rose ^c   Kay, Kevin R ^b   Sanchez, Laura ^b   Carlson, George A ^c   Gomez Isla, Teresa ^b   Albers, Mark W ^b   Spires Jones, Tara L ^b   Hyman, Bradley T ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MCLAUGHLIN RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Perforant pathway; Van Hoesen

Indexed keywords

AMYLOID PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; MALE; MOUSE; NERVE CELL NETWORK; NERVE FIBER DEGENERATION; NERVE PROJECTION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PERFORANT NERVE TRACT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSGENIC MOUSE;

ALZHEIMER'S DISEASE; PERFORANT PATHWAY; VAN HOESEN;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AXONS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NEURAL PATHWAYS; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID; TAU PROTEINS; TISSUE ARRAY ANALYSIS;

EID: 84886710080     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23411     Document Type: Article

References (54)

1. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. 1991. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1:103-116.
2. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
3. Bussiere T, Bard F, Barbour R, Grajeda H, Guido T, Khan K, Schenk D, Games D, Seubert P, Buttini M. 2004. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am J Pathol 165:987-995.
4. Cabalka LM, Hyman BT, Goodlett CR, Ritchie TC, Van Hoesen GW. 1992. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions. Neurobiol Aging 13:283-291.
5. Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, Gomez AC, Levites Y, Edwards SR, Golde TE, Hyman BT, Barnea G, Albers MW. 2012. Abeta alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun 3:1009.
6. Carmel G, Mager EM, Binder LI, Kuret J. 1996. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 271:32789-32795.
7. Chen LL, Van Hoesen GW, Barnes CL, West JR. 1983. Enhanced acetylcholinesterase staining in the hippocampal perforant pathway zone after combined lesions of the septum and entorhinal cortex. Brain Res 272:354-359.
8. Chung RS, Vickers JC, Chuah MI, West AK. 2003. Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury. J Neurosci 23:3336-3342.
9. Collins RT, Linker C, Lewis J. 2010. MAZe: a tool for mosaic analysis of gene function in zebrafish. Nat Methods 7:219-223.
10. de Calignon A, Polydoro M, Suarez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT. 2012. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73:685-697.
11. Geddes JW, Monaghan DT, Cotman CW, Lott IT, Kim RC, Chui HC. 1985. Plasticity of hippocampal circuitry in Alzheimer's disease. Science 230:1179-1181.
12. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. 1997. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41:17-24.
13. Gomez-Isla T, Growdon WB, McNamara MJ, Nochlin D, Bird TD, Arango JC, Lopera F, Kosik KS, Lantos PL, Cairns NJ, Hyman BT. 1999. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain 122(Pt 9):1709-1719.
14. Harris JA, Koyama A, Maeda S, Ho K, Devidze N, Dubal DB, Yu GQ, Masliah E, Mucke L. 2012. Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits. PLoS One 7:e45881.
15. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D. 2010. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067-1081.
16. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
17. Hyman BT. 1996. Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology. Ann Neurol 40:135-136.
18. Hyman BT, Tanzi R. 1995. Molecular epidemiology of Alzheimer's disease. N Engl J Med 333:1283-1284.
19. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. 1984. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170.
20. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. 1986. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 20:472-481.
21. Hyman BT, Kromer LJ, Van Hoesen GW. 1987. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease. Ann Neurol 21:259-267.
22. Hyman BT, Kromer LJ, Van Hoesen GW. 1988. A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50. Brain Res 450:392-397.
23. Hyman BT, West HL, Rebeck GW, Lai F, Mann DM. 1995. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Arch Neurol 52:373-378.
24. Jicha GA, Bowser R, Kazam IG, Davies P. 1997. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128-132.
25. Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM, Hyman BT, Spires-Jones TL. 2009. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A 106:4012-4017.
26. Kopeikina KJ, Polydoro M, Tai HC, Yaeger E, Carlson GA, Pitstick R, Hyman BT, Spires-Jones TL. 2013. Synaptic alterations in the rTg4510 mouse model of tauopathy. J Comp Neurol 521:1334-1353.
27. Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR. 1990. Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience 37:377-385.
28. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ. 2008. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59:214-225.
29. Li L, Tasic B, Micheva KD, Ivanov VM, Spletter ML, Smith SJ, Luo L. 2010. Visualizing the distribution of synapses from individual neurons in the mouse brain. PLoS One 5:e11503.
30. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K. 2012. Trans-synaptic spread of tau pathology in vivo. PLoS One 7:e31302.
31. Lynch G, Matthews DA, Mosko S, Parks T, Cotman C. 1972. Induced acetylcholinesterase-rich layer in rat dentate gyrus following entorhinal lesions. Brain Res 42:311-318.
32. McDonald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM, Selkoe DJ, Ince PG, Walsh DM. 2010. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133(Pt 5):1328-1341.
33. McDonald JM, Cairns NJ, Taylor-Reinwald L, Holtzman D, Walsh DM. 2012. The levels of water-soluble and triton-soluble Abeta are increased in Alzheimer's disease brain. Brain Res 1450:138-147.
34. Mesulam MM. 1998. Some cholinergic themes related to Alzheimer's disease: synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity. J Physiol Paris 92:293-298.
35. Mesulam MM. 2000. A plasticity-based theory of the pathogenesis of Alzheimer's disease. Ann N Y Acad Sci 924:42-52.
36. Micheva KD, Smith SJ. 2007. Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron 55:25-36.
37. Micheva KD, Busse B, Weiler NC, O'Rourke N, Smith SJ. 2010. Single-synapse analysis of a diverse synapse population: proteomic imaging methods and markers. Neuron 68:639-653.
38. Miyamichi K, Amat F, Moussavi F, Wang C, Wickersham I, Wall NR, Taniguchi H, Tasic B, Huang ZJ, He Z, Callaway EM, Horowitz MA, Luo L. 2010. Cortical representations of olfactory input by trans-synaptic tracing. Nature 472:191-196.
39. Rosene DL, Van Hoesen GW. 1977. Hippocampal efferents reach widespread areas of cerebral cortex and amygdala in the rhesus monkey. Science 198:315-317.
40. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH. 2005. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309:476-481.
41. Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai BJ, Hyman BT. 2005. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 25:7278-7287.
42. Van Hoesen GW. 1985. Neural systems of the non-human primate forebrain implicated in memory. Ann N Y Acad Sci 444:97-112.
43. Van Hoesen GW, Hyman BT. 1990. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 83:445-457.
44. Van Hoesen G, Pandya DN. 1975a. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. I. Temporal lobe afferents. Brain Res 95:1-24.
45. Van Hoesen GW, Pandya DN. 1975b. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections. Brain Res 95:39-59.
46. Van Hoesen GW, Pandya DN, Butters N. 1972. Cortical afferents to the entorhinal cortex of the rhesus monkey. Science 175:1471-1473.
47. Van Hoesen GW, Rosene DL, Mesulam MM. 1979. Subicular input from temporal cortex in the rhesus monkey. Science 205:608-610.
48. Van Hoesen GW, Hyman BT, Damasio AR. 1986. Cell-specific pathology in neural systems of the temporal lobe in Alzheimer's disease. Prog Brain Res 70:321-335.
49. William CM, Andermann ML, Goldey GJ, Roumis DK, Reid RC, Shatz CJ, Albers MW, Frosch MP, Hyman BT. 2012. Synaptic plasticity defect following visual deprivation in Alzheimer's disease model transgenic mice. J Neurosci 32:8004-8011.
50. Witter MP. 2007. The perforant path: projections from the entorhinal cortex to the dentate gyrus. Prog Brain Res 163:43-61.
51. Wolozin BL, Pruchnicki A, Dickson DW, Davies P. 1986. A neuronal antigen in the brains of Alzheimer patients. Science 232:648-650.
52. Wu HY, Hudry E, Hashimoto T, Kuchibhotla K, Rozkalne A, Fan Z, Spires-Jones T, Xie H, Arbel-Ornath M, Grosskreutz CL, Bacskai BJ, Hyman BT. 2010. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci 30:2636-2649.
53. Wu L, Sonner PM, Titus DJ, Wiesner EP, Alvarez FJ, Ziskind-Conhaim L. 2011. Properties of a distinct subpopulation of GABAergic commissural interneurons that are part of the locomotor circuitry in the neonatal spinal cord. J Neurosci 31:4821-4833.
54. Yasuda M, Mayford MR. 2006. CaMKII activation in the entorhinal cortex disrupts previously encoded spatial memory. Neuron 50:309-318.